Chemically modified collagen: a natural biomaterial for tissue replacement.

Area of Science:

• Biomaterials Science
• Biochemistry
• Tissue Engineering

Background:

• Glutaraldehyde crosslinking enhances collagen stability but faces challenges like calcification and immune reactions.
• Existing crosslinking methods have limitations in long-term implant performance.

Purpose of the Study:

• To improve glutaraldehyde crosslinking of collagenous tissues for bioprostheses.
• To reduce implant biodegradation, immune responses, and calcification.
• To minimize cytotoxicity of residual crosslinking agents.

Main Methods:

• Enhanced crosslinking by bridging activated carboxyl groups with diamines.
• Utilizing glutaraldehyde to crosslink collagen and introduced amines.
• Covalently binding diphosphonates (3-APD) and chondroitin sulfate to collagen.

Main Results:

• Reduced tissue degradation and nearly eliminated humoral antibody induction.
• Significantly reduced potential for calcification with bound diphosphonates and chondroitin sulfate.
• Reduced platelet aggregation, nearly eliminated by chondroitin sulfate binding.
• Minimized cytotoxicity through neutralization, rinsing, and bacteriostatic storage.

Conclusions:

• Enhanced crosslinking strategies improve collagenous biomaterial safety and efficacy.
• Combined crosslinking and covalent binding offer a promising approach for advanced bioprostheses.
• These modifications address key limitations of glutaraldehyde-crosslinked collagen implants.